Ledger.Open graph →

SEC Form D · Amendment · filed July 23, 2010

NIIKI PHARMA INC

Offering

$7.0M

Sold

$5.0M

Exemption

—

Industry

Biotechnology

Location

HOBOKEN, NJ

Type

—

People & firms on this filing (4)

Hooshmand Sheshbaradaran · Hoboken, NJExec · Director Ali Ardakani · Hoboken, NJExec · Director Jeffrey S. Podell · Miami, FLExec · Director Richard J. Rosenstock · Miami, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗